Overdiagnosis of thyroid cancer in the United States remains a persistent problem, according to a study published online Feb.

Thyroid cancer continues to be overdiagnosed, though the survival rate remains unchanged, according to a study published Feb. 5 in The Lancet Diabetes & Endocrinology. Here are five notes from the ...

Laboratory for Research on the Structure of Matter (LRSM), University of Pennsylvania, Philadelphia, United States ...

The series of spin rides is a fundraiser for Memorial Sloane Cancer Center, which specializes in the treatment and diagnosis ...

Cancer is affecting increasing numbers of young women with the hormone oestrogen thought to play to a central role ...

The phase 2 RESET-C trial (NCT05662527), presented at the 2025 ASCO Gastrointestinal Cancer Symposium, demonstrated that a single cycle of neoadjuvant pembrolizumab (Keytruda) was both efficacious and ...

Consequently, augmenting ferroptosis in thyroid cancer cells could constitute a viable therapeutic approach ... the possible intolerance of ferroptosis targeting, and the long cycle of clinical ...

Now, a UB-led study describes for the first time a molecular mechanism that could drive the design of strategies to eliminate senescent cells in cancer patients. Senescent cells can be caused by ...

This means it's often next to impossible to avoid harming healthy cells, so oncologists are often unable to use as high a dose as they would like, says Loo. Cancer specialists have long believed ...

In a significant step forward for India’s cancer treatment, Immuneel Therapeutics, a leading cell and gene therapy statrtup backed by entrepreneur Kiran Mazumdar-Shaw, has unveiled Qartemi, the ...

Case presentation: A 60-year-old female farmer was diagnosed with thyroid cancer and breast cancer and then developed dermatomyositis after two curative surgeries and adjuvant chemotherapy.